Risk stratification for CTCL
1 Views
administrator
08/09/23
Lauren Pinter-Brown, MD, of UCI Health, Chao Family Comprehensive Cancer Center, Orange, CA, discusses the debate around risk stratification for cutaneous T-cell lymphoma (CTCL) based on the diagnosis, the stage of disease, and other presentations of the disease, as well as existing prototype registries including PROCLIPI. This interview took place during the ninth annual meeting of the Society of Hematologic Oncology (SOHO 2021) congress.
-
Category
Show more
Facebook Comments
No comments found